menu
    • menu

    Company profile for Odonate Therapeutics

    NEW Drugs in Dev: 1
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. We are a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class o...
    Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. We are a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Odonate TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Diego, CA 92121
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.odonate.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/odonatetherapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/odonatetx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Odonate Announces Expected Delisting of Its Stock
    Odonate Announces Expected Delisting of Its Stock

    07 Jan 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220107005100/en

    BUSINESSWIRE
    07 Jan 2022
    Share Share
    Odonate Announces Planned Return of Capital to Stockholders
    Odonate Announces Planned Return of Capital to Stockholders

    17 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211117005445/en

    BUSINESSWIRE
    17 Nov 2021
    Share Share
    Odonate Therapeutics Announces Financial Results for the Three and Nine Months
    Odonate Therapeutics Announces Financial Results for the Three and Nine Months

    10 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211110005549/en/Odonate-Therapeutics-Announces-Financial-Results-for-the-Three-and-Nine-Months-Ended-September-30-2021

    BUSINESSWIRE
    10 Nov 2021
    Share Share
    Odonate Therapeutics Announces Financial Results
    Odonate Therapeutics Announces Financial Results

    27 Jul 2021

    // PR NEWSWIRE

    https://www.businesswire.com/news/home/20210727005343/en

    PR NEWSWIRE
    27 Jul 2021
    Share Share
    Odonate abandons breast cancer chemo drug, closes its doors
    Odonate abandons breast cancer chemo drug, closes its doors

    23 Mar 2021

    // A. Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/odonate-abandons-breast-cancer-chemo-drug-closes-its-doors

    A. Al Idrus FIERCE BIOTECH
    23 Mar 2021
    Share Share
    Those NDA plans Odonate had for mid-'21? They're being scrapped
    Those NDA plans Odonate had for mid-'21? They're being scrapped

    22 Mar 2021

    // John Carroll ENDPTS

    https://endpts.com/those-nda-plans-odonate-had-for-mid-21-theyre-being-scrapped-along-with-the-entire-biotech-in-a-sudden-implosion/

    John Carroll ENDPTS
    22 Mar 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search